The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Real Estate
  • Technology
  • Education
  • Travel
  • Marketing

Olympus Acquires Veran Medical Technologies, Inc.
The PennZone/10102444

Trending...
  • Cleveland County Goat Farm NC Kikos Featured in "Feature Farmer Friday" Documentary
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
CENTER VALLEY, Pa. and TOKYO, Dec. 30, 2020 /PRNewswire/ -- Olympus Corporation today announced that it has finalized the acquisition of Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, following the definitive agreement the two companies signed December 4, 2020. With this acquisition by Olympus subsidiary Olympus Corporation of the Americas (OCA), Olympus gains VMT's global sales network, marketing, manufacturing, R&D, and other functions to expand the Olympus respiratory product portfolio.

Lung cancer is the leading cause of cancer-related deaths globally.1 With increased awareness and more lung cancer screenings using low-dose computed tomography (CT), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. VMT's SPiN Thoracic Navigation System® and related devices are specifically designed to help physicians navigate to, localize, and sample peripheral pulmonary lesions. Together with the existing Olympus respiratory portfolio that includes radial endobronchial ultrasound (EBUS) and thin bronchoscopes, VMT's navigational system and related devices provide a powerful combination of imaging, access and precision for pulmonologists seeking to diagnose and determine the stage of a patient's lung cancer.

More on The PennZone
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
  • Mobile Copywriter Celebrates 13 Years of Content Creation and SEO Services
  • Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
  • Over 98% of crypto owners globally don't declare taxes, new report find

"We are very excited about the synergies this acquisition creates. With the deal now closed, as one company we are able to combine Olympus' expertise and clinical history in minimally invasive technology with the innovation in navigation systems of Veran Medical Technology to improve workflow and patient care in lung cancer," said Lynn Ray, Vice President and General Manager of the Global Respiratory Business Unit for Olympus Corporation. "Olympus is committed to providing the medical community with the best tools possible to use in their fight against cancer. With the advent of EBUS-guided transbronchial needle aspiration (EBUS-TBNA) in 2004, Olympus brought patients the benefit of more accurate diagnosis and staging, to improve patient outcomes and care. We are thrilled to be at the forefront of development in this rapidly evolving area of respiratory care."

The acquisition will provide immediate incremental revenue and an experienced sales team within the U.S. market. VMT's advanced and proven navigation technology, together with Olympus' respiratory portfolio, strengthens and enhances Olympus' global position as a medical technology innovator.

As part of its current Corporate Strategy, Olympus vowed to "focus and scale" its Therapeutic solutions Division (TSD). To accelerate the process and provide greater agility, Olympus made OCA the TSD headquarters, recognizing the significant growth opportunities in North America. Olympus also identified three core medical fields to prioritize and has since focused on gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.

More on The PennZone
  • Happreneurs™ Business Community Launches Pittsburgh, PA Chapter with Powerful Network of Founding Leaders
  • TicTac Group acquires French EdTech company Distrisoft
  • Rhys-Davies, Wright, Norris, Jacinto Highlight Latest Wave of FAN EXPO Philadelphia Celebrity Guests
  • Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
  • Genpak Announces Closure of Utah Manufacturing Facility

For additional information, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States."

(available at: https://www.olympus-global.com/news/ir/2020/)

1 WHO data:  https://www.who.int/news-room/fact-sheets/detail/cancer

About Olympus' Therapeutic Solutions Division
In its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com.

SOURCE Olympus

Related Links

http://www.olympus.com/
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
  • Why We're Holding the Line on Pricing
  • Moravian Academy Announces New Full-Tuition Impact Scholarship for Upper School Students
  • AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • National Focus Turns to Global Conflict, Families of Veterans Lost to Suicide Call for Recognition
  • New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • ATTAIN Profiles the Invisible Billionaire Who Started With $75 and Died the Richest Man in A
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
  • NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
  • QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
  • Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
  • Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
  • New Book Synthesizes Six Peer-Reviewed Research Programs Into Unified Framework for Consciousness
  • The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • USA Best Book Awards Finalist What Love Leaves Behind Releases March 24

Popular on PennZone

  • Postmortem Pathology Expands Independent Autopsy Services Across Colorado
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • Mecpow M1: A Safe & Affordable Laser Engraver Built for Home DIY Beginners
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
  • $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships

Similar on PennZone

  • The Inner Power of Emotional Self-Leadership
  • Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
  • Mobile Copywriter Celebrates 13 Years of Content Creation and SEO Services
  • Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
  • Happreneurs™ Business Community Launches Pittsburgh, PA Chapter with Powerful Network of Founding Leaders
  • TicTac Group acquires French EdTech company Distrisoft
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • EFA Announces 2026 Editorial Rate Chart
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us